Jounce Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

324,786

Value ($000)

601

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	601	0.0%	324,786	3/31/2023
2022 Q4	2/13/2023	396	0.0%	356,638	12/31/2022
2022 Q3	11/14/2022	779	0.0%	333,156	9/30/2022
2022 Q2	8/12/2022	1,179	0.0%	389,280	6/30/2022
2022 Q1	5/13/2022	2,258	0.0%	332,588	3/31/2022
2021 Q4	2/8/2022	2,894	0.0%	346,722	12/31/2021
2021 Q3	11/15/2021	2,605	0.0%	350,647	9/30/2021
2021 Q2	8/13/2021	2,909	0.0%	427,885	6/30/2021
2021 Q1	5/12/2021	2,594	0.0%	252,600	3/31/2021
2020 Q4	2/11/2021	2,196	0.0%	313,640	12/31/2020
2020 Q3	11/16/2020	2,526	0.0%	309,571	9/30/2020
2020 Q2	8/14/2020	2,230	0.0%	323,172	6/30/2020
2020 Q1	5/14/2020	932	0.0%	196,279	3/31/2020
2019 Q4	2/14/2020	1,507	0.0%	172,593	12/31/2019